Joel Pearlman Selected Research

Verteporfin (Visudyne)

1/2017

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joel Pearlman Research Topics

Disease

2	Retinal Vasculitis 07/2021 - 07/2020
2	Inflammation (Inflammations) 07/2021 - 07/2020
2	Macular Degeneration (Age-Related Maculopathy) 07/2020 - 01/2017
1	Choroidal Neovascularization 01/2017
1	Edema (Dropsy) 01/2014
1	Retinal Vein Occlusion 01/2014
1	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2006
1	Diabetes Mellitus 10/2006
1	Ischemia 03/2002
1	Retinal Neovascularization 03/2002

Drug/Important Bio-Agent (IBA)

2	brolucizumabIBA 07/2021 - 07/2020
2	Ranibizumab (Lucentis)FDA Link 01/2017 - 01/2014
2	Retinaldehyde (Retinal)IBA 10/2006 - 03/2002
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2021
1	Verteporfin (Visudyne)FDA Link 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Fluorescein (Funduscein)FDA LinkGeneric 10/2006
1	Bevacizumab (Avastin)FDA Link 10/2006
1	Biological ProductsIBA 10/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2002
1	pigment epithelium-derived factorIBA 03/2002

Therapy/Procedure

1	Aftercare (After-Treatment) 07/2020
1	Therapeutics 01/2017
1	Photochemotherapy (Photodynamic Therapy) 01/2017
1	Injections 01/2014
1	Lasers (Laser) 01/2014
1	Light Coagulation 01/2014